Therapeutic strategies for autoimmune hepatitis

Digestive Diseases

Volumn 29, Issue 4, 2011, Pages 411-415

  Manns, Michael P ^a   Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anti immunity; Autoimmune hepatitis; Azathioprine; Budesonide; Immunosuppression; Steroids

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; BUDESONIDE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; AUTOIMMUNE HEPATITIS; BONE DISEASE; CHEMICAL ANALYSIS; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GLAUCOMA; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOW DRUG DOSE; MOON FACE; PORTAL HYPERTENSION; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL; THROMBOCYTOPENIA; WEIGHT GAIN;

ANIMALS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; REMISSION INDUCTION;

EID: 80052426810     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000329805     Document Type: Article

References (18)

1. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
2. Czaja AJ, Manns MP: Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010; 139: 58-72.e4.
3. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM: AASLD Practice Guidelines: Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213.
4. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW: Simplified diagnostic criteria for autoimmune hepatitis. Hepatology 2008; 48: 169-176. (Pubitemid 351975541)
5. Czaja AJ, Lindor KD: Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology 2000; 119: 1312-1316.
6. Summerskill WH, Kormann MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: Dose titration, standard dose and combination with azathioprine compound. Gut 1975; 16: 876-883.
7. Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, Bahr MJ, Günther R, Hultcrantz RW, Spengler U, Lohse AW, Szalay F, Farkkilä M, Proels M, Strassburg CP, European AIH-BUC-Study Group: Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010; 139: 1198-1206.
8. Stellon AJ, Hegarty JE, Portmann B, Williams R: Randomized controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Lancet 1985; 1: 668-670. (Pubitemid 15134821)
9. Manns MP, Strassburg CP: Autoimmune hepatitis; in O' Grady JG, Lake JR, Howdle DP (eds): Comprehensive Clinical Hepatology. London, Mosby, 2000, vol 16, pp 1-14.
10. Johnson PJ, McFarlane IG, Williams R: Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 958-963.
11. Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, Taheri H, Kamalian N, Sotoudeh M: Cyclosporine A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001; 46: 1321-1327. (Pubitemid 32523281)
12. Alvarez F, Ciocca M, Canero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M, Gonzalez T, Jara-Vega P, Camarena C, Brochu P, Drut R, Alvarez E: Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999; 30: 222-227. (Pubitemid 29071183)
13. Danielsson A, Prytz H: Oral budesonide for treatment of autoimmune chronic active hepatitis. Aliment Pharmacol Ther 1994; 8: 585-590. (Pubitemid 24381357)
14. Schüler A, Manns MP: Treatment of autoimmune hepatitis; in Arroyo V, Bosch J, Rodes J (eds): Treatment in Hepatology. Paris, Masson, 1995, pp 375-383.
15. Wiegand J, Schüler A, Kanzler S, Lohse A, Beuers U, Kreisel W, Spengler U, Koletzko S, Jansen PL, Hochhaus G, Möllmann HW, Pröls M, Manns MP: Budesonide in previously untreated autoimmune hepatitis. Liver Int 2005; 25: 927-934. (Pubitemid 41404011)
16. Richardson PD, James PD, Ryder SD: Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000; 33: 371-375. (Pubitemid 30663373)
17. Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, Lilly LB, Heathcote EJ, Deschenes M, Lee SS, Steinbrecher UP, Yoshida EM: Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: The Canadian Association for the Study of the Liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver Int 2005; 25: 723-727. (Pubitemid 41038652)
18. Hennes EM, Oo YH, Schramm C, et al: Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 2008; 103: 3063-3070.